Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
An extension study to evaluate safety and tolerability of up to 3 additional courses of IM
alefacept in patients with chronic plaque psoriasis who have been previously treated with 1
or 2 courses of IM alefacept.